Dr Pascal Sati, PhD is an Associate Professor in the Department of Neurology at Cedars-Sinai Medical Center in Los Angeles, California. He graduated his PhD in Physics from Aix-Marseille University in France and completed his postdoctoral training at the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis, Missouri, and at the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland. He is the founder and director of the Neuroimaging Program at Cedars-Sinai which focuses on the discovery, development and validation of novel imaging biomarkers for advancing precision medicine in Neurology.

Dr. Sati is the inventor of MRI techniques, (T2* EPI and FLAIR*) dedicated to the detection of advanced brain T2* EPI and FLAIR*. imaging biomarkers for Multiple Sclerosis (MS), such as the Central Vein Sign (CVS) and Paramagnetic Rim Lesions (PRL). These MRI techniques have been widely validated by international multicenter diagnostic studies, and are now being translated into clinical practice for diagnostic evaluation of MS. Dr. Sati serves as a principal investigator of several US research grants from the National Institutes of Health, the Department of Defense and the National MS Society, and is a steering committee member of the North American Imaging in MS (NAIMS) Cooperative.